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Mucins are large glycoproteins responsible for the rheological 
properties of normal mucus gels. So far 5 secreted gel-form-
ing mucins (MUC2, 5AC, 5B, 6, 19), 3 secreted non-gel-
forming mucins (MUC7, 8, 9), 10 membrane-bound mucins 
(MUC1, 3A, 3B, 4, 11, 12, 13, 16, 17, 20) and 3 unclassified 
mucins (MUC14, 15, 18) have been identified.1,2
Mucin genes are independently regulated and their expres-
sion is organ and cell type-specific.3 MUC2 is the dominant 
mucin in the human colon and is a ‘large’ mucin for which 
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Summary
Objectives. To characterise mucins in cancer of the colon 
and compare these with controls using stringent biochemical 
measures to avoid endogenous proteolysis. 
Design. Crude mucus scrapings were collected from 12 
specimens obtained by colectomy. Specimens from 3 traumatic 
colectomies and 1 sigmoid volvulus were used as controls, 
and compared with 6 specimens from colons resected for 
adenocarcinoma and 2 irradiated colons.
Subjects. The median age of the 4 female patients was 76 
years (range 49 - 82 years), and of the 8 male patients 46.5 
years (range 16 - 74 years).
Results and conclusions. The crude mucus scrapings in 
the 9 specimens ranged in weight from 353 mg to 7 697 mg 
(median 4 928 mg). The median of purified mucin in the 9 
specimens was 0.72 µg/mg wet weight of scraped material. 
Eight samples gave non-extractable pellet material, and 
were treated with DTT to reduce disulphide bonds for further 
analysis. One of these 8 pellets was resistant to reduction 
and had to be digested with papain before analysis. Only 5 
of these pellets had mucin. Gel filtration and SDS-PAGE 
(sodium dodecyl sulphate polyacrylamide gel electrophoresis) 
analysis revealed different populations of mucin based 
on size and extent of degradation. Western blotting and 
immunohistochemical analysis confirmed the presence of 
MUC2 in all samples, MUC5AC in 2 and MUC5B in 5 diseased 
specimens. Immunohistochemical analysis showed that there 
was no MUC1 in the normal specimens, MUC1 apoprotein 
(MUC1 core) in 2 cancer specimens and MUC1 in 1 cancer 
specimen. Histochemical analysis showed that normal tissue 
expressed neutral and acidic mucins and diseased specimens 
predominantly expressed acidic mucins. The electrophoretic 
behaviour of MUC2 in sigmoid volvulus was different from that 
in cancer of the colon.
Abbreviations
DTT = dithiothreitol, H&E = haematoxylin and eosin, PAS 
= periodic acid Schiff, HID = high iron diamine, CsCl = 
caesium chloride, GuHCl = guanidinium chloride, EDTA 
= ethylenediaminetetra-acetic acid disodium salt, NEM = 
N-ethylmaleimide, PMSF = phenylmethysulphonyl fluoride, 
SDS = sodium dodecyl sulphate, PAGE = polyacrylamide 
gel electrophoresis, NaCl = sodium chloride, HRPO = 
horseradish peroxidase, TBST = tris-buffered saline tween-
20, TBS = tris-buffed saline tween, Vi = included volume, Vo 
= void volume.
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cDNA has been fully sequenced.4 The development of the 
majority of colorectal carcinomas is associated with a dimin-
ished expression of MUC2 in the tumour cells.5 However, 
Bresalier et al.6 showed that mucinous colonic carcinomas are 
more likely to metastasise, and that inhibition of mucin syn-
thesis is associated with a reduction of metastatic potential.
The physiochemical and biological properties of mucus 
are largely conferred by mucins, large O-glycosylated, sticky, 
visco-elastic glycoproteins responsible for the rheological 
properties of normal mucus gels.7 Mucus forms a continu-
ous, insoluble adherent gel layer in the gastro-intestinal tract, 
which protects the underlying mucosa from the hostile envi-
ronment of the lumen.7-9
A biochemical study10 of mucin obtained from specimens 
of macroscopically normal human colon as well as those 
resected during cancer surgery, suggested that colonic mucin 
is an insoluble complex that cannot be solubilised by chao-
tropic agents. These researchers employed the most stringent 
biochemical procedures to extract and purify mucin, making 
this probably the first definitive biochemical study of human 
colonic mucin in disease. However, the study focused on the 
characterisation of colonic mucin and did not 
compare differences between normal and diseased colonic 
mucin.10
In the present study we isolated mucins from colectomy 
specimens according to the method of Hermann et al.;10 
coupled with immunohistochemical studies11 we determined 
the changes in the mucous secretions of colonic epithelia in 6 
cancer patients and 2 irradiated cases.
Materials and methods
The study was approved by the University of Cape Town 
Research Ethics Committee (REC REF 149/2002). Crude 
mucus scrapings were collected from the resected colon in 
12 cases.  Four of the resections (3 for trauma and 1 for 
sigmoid volvulus) were used as controls. Six specimens 
were collected from colons containing an adenocarcinoma 
and 2 from irradiated bowel (Table I). The 3 trauma speci-
mens were delivered to us in formalin and were only suit-
able for histological and immunohistochemical analysis.
Antibodies to the different mucins were obtained from 
appropriate sources; the details may be obtained by con-
tacting the authors, as may those for the processes of extrac-
Table I. PaTIeNT DaTa aND HISTOlOGICal DeTaIlS
Laboratory         Age                     Histological
number              (yrs)       Gender             Specimen                  Histological assessment             grading
C1                      33       M                       left colon                  Normal colonic mucosa             N/a
C2                       16       M                       Right colon               Normal colonic mucosa              N/a
C3                      22       M                       left colon                  Normal colonic mucosa             N/a
C4                      77       F                        Sigmoid resection    No tumour. Normal colonic            N/a
                  mucosa with no evidence of 
                  inflammation or ulceration 
S1                      49       F                       Sigmoid colon         Colonic adenocarcinoma                2/3
                                 with polyp               extending into the 
                  muscularis propria
S2                      75       F                        anus and rectum     Chronic radiation-induced              N/a
                                (biopsy)              change in the rectal mucosa
S3                      42       M                       anal verge post       benign squamous epithelium        N/a
                                radiation (biopsy)     with underlying fibrous 
                  stroma containing mildly 
                  ecstatic vessels
S4                      55       M                       Colonic polyps         Pedunculated polyp.                       1/3
                  adenocarcinoma
S5                      70       M                       Rectum              Colonic adenocarcinoma that       1/3
                  infiltrates the muscularis     
                       propria and extends into the 
                  subserosa 
S6                      51       M                       Sigmoid colon          Rectal mucosa shows an               Not graded
                                 and rectum              invasive colonic adenocar-
                  cinoma that arises from the 
                  surface, infiltrates through    
                      the muscularis mucosa into 
                  the submucosa
S7                      82       F                       left colon              Midway descending colon.             1/3
                  adenocarcinoma
S8                      74       M                       left colon             Midway descending colon.            1/3
                  adenocarcinoma
Median              53       -                         -                                 -                -
N/A = not available.
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tion and purification, gel filtration, enzymatic digestion, 
polyacrylamide gel electrophoresis, agarose gel electrophore-
sis, Western blotting, and histochemical, and immunohisto-
chemical analysis.
Results
Table I lists the patients, the type of specimen obtained, and 
a histological assessment of each specimen.  The crude wet 
weight of mucus harvested had a median of 4 928 mg (range 
353 - 7 697 mg). A median of 0.72 μg/mg wet weight purified 
mucin was obtained from the soluble portion of the crude 
scrapings. The non-extractable pellet material obtained after 
homogenisation and centrifugation had to be further treated 
and yielded mucin in 5 of 8 cases. The pure mucin fractions, 
free of contaminant protein and nucleic acid,12 were pooled, 
dialysed exhaustively against distilled water and freeze-dried 
(Fig. 1).
Fig. 2a shows a representative gel filtration profile of the 
soluble mucus from a patient with carcinoma. The soluble 
material contained a mixture of mucin (that eluted in the 
void volume (Vo), suggesting that there was a mixture of 
large and polymeric (gel-forming) mucin)13-15 and degraded 
mucins and non-mucin protein material that eluted in the 
included volume of the column (Vi) (Fig. 2a). Purified mucin 
also had a mixture of gel-forming polymeric (Vo) and degrad-
ed subunit mucin (Vi).
14 The profile (Fig. 2b) revealed differ-
ent size populations of mucins in the Vi suggesting a variable 
degradation of mucin in disease. Most of the insoluble pellet 
material eluted in the included volume of the column as 
expected (Fig. 2c).15
Mucus glycoprotein was analysed by SDS/PAGE (sodium 
dodecyl sulphate polyacrylamide gel electrophoresis). An 
intense PAS stained band was observed at the origin on top 
of the gel.  This was interpreted as the presence of mucus 
glycoproteins that had not entered the gel because of their 
high-molecular-weight (Fig. 3). The faint background of 
material in each column again suggests the presence of some 
degradation of colonic mucin in each of the patients. 
All specimens (Fig. 4, lanes 3 - 6 and 8 - 11), except S4 
lane 7, were positive for MUC2 in varying degrees, with less 
visible material for patient S5 (Fig. 4, lane 6) and patients 
S1 - 3 after treatment to reduce the disulphide bonds of the 
mucin. There was no visible material for patient S4 (Fig. 4, 
lane 7) who had a cancerous pedunculated polyp. The glyco-
form of MUC2 in the patient with a sigmoid volvulus (Fig. 4, 
lane 3) was different from that in the cancer patients.
MUC5AC, on the other hand, is a gastric mucin type 
and as such it is not anticipated in the colon. In this study, 
the patient with the adenocarcinomatous pedunculated 
polyp was positive for MUC5AC with Western blotting (not 
shown). Patient S1 (colonic adenocarcinoma) showed some 
reactivity for MUC5B, while patient C4R (Fig. 4, lane 9) 
(sigmoid volvulus) was more strongly positive for MUC5B 
(not shown).
Fig. 1. Second CsCI density gradient centrifugation of human 
colonic mucus. CsCl was added to semi-purified mucins 
obtained from the first CsCl density centrifugation spin to 
give a starting density of 1.39 - 1.40 g/ml. after centrifugation 
(40 000 rpm for 48 h) the tubes were fractionated into 8 equal 
fractions and the density of each fraction was measured (Å). 
The fractions were then assayed for protein absorbance at 
280 nm (u) and analysed for carbohydrate with PaS at 555 
nm (n).
Fig. 2. Gel filtration analysis of soluble mucus and purified 
mucin on a Sepharose Cl-2b column. Mucus scrapings were 
extracted in 6 M guanidinium chloride (GuHCl) containing 10 
mM eDTa, 5 mM NeM and 1 mM PMSF, homogenised, and 
spun at 6 000 g for 1 h to remove insoluble debris. an aliquot 
(0.7 ml) of the soluble mucus in the supernatant was loaded on 
the column (a). after solubilisation mucins were isolated and 
purified by density gradient ultra-centrifugation, twice for 48 h 
at 40 000 rpm (b). Insoluble material resistant to extraction and 
reduction with DTT was digested with papain (see ‘Materials 
and methods’ section) and the mucin was purified (c). The 
column was eluted with 0.2 M NaCl: 0.02% sodium at a flow 
rate of 2.0 ml/min at room temperature. Fractions were ana-
lysed for carbohydrate with PaS at 555 nm (n) and protein 
absorbance at 280 nm (l). 
a
b
c
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Table II summarises the histological results. All controls 
had a mixture of neutral and acidic mucins (Fig. 5A, Table 
III), the latter being largely of the sulphated type (Fig. 5C, 
Table III). The sigmoid volvulus had less neutral and more 
acidic mucin of both the sulphated and non-sulphated type 
showing staining with both HID and alcian blue respec-
tively. Acidic mucin was less in the cancer specimens than 
in controls. However acidic mucin in cancer specimens was 
predominantly positive for Alcian blue while the sulphated 
HID-positive mucin was largely absent in disease (Table III). 
There was less neutral mucin in the diseased tissue than in 
controls. 
Immunohistochemistry
A summary of these results is given in Table III. Patient S4 
was positive for MUC1 (Fig. 5E). Normal specimens showed 
no MUC1 expression, while 2 patients (S4 and S7) showed 
reactivity for MUC1c (mucin apoprotein) (Fig. 5F) and 
patient S9 was positive for MUC5AC (Table III). MUC2 
was positive in controls and diseased specimens (Fig. 5G).
Fig. 3. a 10% SDS-PaGe gel of purified colonic mucins. 
Mucins were purified as described in the materials and 
methods section. lane 1, sigmoid volvulus (C4); lane 2, 
colonic adenocarcinoma (S1); lane 3, radiation-induced 
damage in rectum (S2); lane 4, adenocarcinoma (S4); 
lane 5, colonic adenocarcinoma (S5); and lane 6 colonic 
adenocarcinoma (S8). The gel was stained for glycopro-
tein with PaS. See Table II for more details of patients’ 
histological diagnoses.
    1          2         3         4           5         6
Fig. 4. Western blotting of purified colonic mucin using rabbit 
anti-MUC2 polyclonal antibody. Samples were separated on a 
10% agarose gel and transferred to nitrocellulose membrane 
by vacuum blotting. The membrane was incubated for 1 h in 
5% (w/v) low-fat milk powder in TbS, 0.05% Tween-20 (TbST) at 
4ºC to block for nonspecific binding. The membrane was then 
incubated with rabbit anti-MUC2 polyclonal antibody for  2 h 
and then diluted in 5% (m/v) low-fat milk powder in TbST at 
1:100. The membrane was then washed 3 times for 5 min with 
TbST and incubated for 1 h with HRPO-linked secondary anti-
body (goat anti-rabbit) diluted in 5% (m/v) low-fat milk powder 
in TbST at a dilution of 1:2 000. after another TbST wash (3 
times for 5 min), bands were visualised with an eCl detection 
kit. 
lanes: 1, cervical mucin (+ve control); 2, normal sputum (-ve 
control); 3, sigmoid volvulus with no evidence of tumour or 
ulceration (C4); 4, colonic adenocarcinoma (S1); 5, benign 
squamous epithelium and underlying fibrous stroma (S3); 6, 
colonic adenocarcinoma (S5); 7, adenocarcinoma (S4); 8, sig-
moid volvulus (C4); 9, colonic adenocarcinoma (S1); 10, chron-
ic radiation-induced damage in the anus and rectum (S2).
Fig. 5. Histochemical results (a - D) showing a, normal colon 
stained with PaS/aIcian blue (40X), b, adenocarcinoma 
stained with H & e (10X), C, normal colon stained with HID 
(10X) and D, adenocarcinoma stained with HID (10X).
Immunohistochemistry (e - G) of mucin expression in a mod-
erately differentiated adenocarcinoma of the colon with MUC1 
expression (40X) is shown in e, MUC1 CORe expression (40X) 
in F, and MUC2 expression (40X) in G.
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Table II. SUMMaRY OF MUCIN HISTOlOGY ReSUlTS
Laboratory  
number Histochemistry                H and E stain   PAS/Alcian blue   HID/Alcian blue
C1          ¸                           Normal   Mixture of acidic and  Sulphated mucin
                            No tumour   neutral mucins (2+)  (2+)
C2          ¸                           Normal  Mixture of acidic  Sulphated mucin
                            No tumour   and neutral   (2+)
      mucins (2+) 
C3          ¸                           Normal   Mixture of acidic and  Sulphated mucin
                            No tumour   neutral mucins  (2+)
       (2+)  
C4          ¸                           Normal   Predominantly acidic  Predominantly
                            No tumour   mucin (2+) with   non-sulphated
                            Sigmoid volvulus focal neutral mucin (1+) mucin (2+)
         Sulphated mucin  
         (1+)
S1          ¸                           Moderately   Predominantly   Sulphated mucin
                            differentiated   extracellular neutral (2+)
                            colon    mucin (2+) 
                            adenocarcinoma Focal acidic mucin (1+)
S2           ×                           No tissue   No tissue available  No tissue available
                            available
S3           ×                           No tissue   No tissue available No tissue available
                            available
S4          ¸                           Moderately differe- Intracytoplasmic  Non-sulphated
                            ntiated colon   neutral mucin (1+)  mucin (1+)
                            adenocarcinoma   
S5          ¸                           Moderately   apical neutral   No sulphated
                            differentiated   mucin (1+)   mucin
                            colon    Intracytoplasmic  Carboxylated
                            adenocarcinoma acidic mucin (1+)  mucins
S6          ¸                           Moderately   Intracytoplasmic Non-sulphated
                            differentiated   acidic mucin (1+) mucin (+1)
                            colon    apical neutral
                            adenocarcinoma mucin (1+)
S7          ¸                           Moderately   acidic mucin (1+) Non-sulphated  
                            differentiated     mucin (1+)
                            colon
                            adenocarcinoma  
S8          ¸                           Moderately   acidic mucin (1+)  Non-sulphated
                            differentiated      mucin (1+)
                            colon
                                         adenocarcinoma 
Table III. SUMMaRY OF MUCIN IMMUNOHISTOCHeMICal ReSUlTS
Laboratory                                               MUC1          
number            Immunohistochemistry         MUC1            core            MUC2           MUC5AC        MUC5B           MUC6
C1                                   ¸                        -ve               -ve              +ve (3+)         -ve                  +ve (4+)          -ve
C2                                   ¸                        -ve               -ve              +ve (3+)         -ve                   +ve (4+)          -ve
C3                                   ¸                        -ve               -ve              +ve (3+)    -ve                  +ve (2+)          -ve
C4?                                 ¸                        -ve               -ve              +ve (2+)    -ve                  +ve (1+)          -ve
S1                                   ¸                        -ve               -ve              +ve (4+)    -ve                  +ve (1+)          -ve
S4                                   ¸                        +ve (2+)       +ve (2+)      +ve (1+)    -ve                  -ve                   -ve
S5                                   ¸                        -ve               -ve (< 5%)    +ve (1+)    -ve                  -ve                   -ve
S6                                   ¸                        -ve               -ve              -ve (< 5%)    -ve                  -ve                   -ve
S7                                   ¸                        -ve               +ve (1+)      +ve (1+)    -ve                  +ve (1+)           -ve
S8                                   ¸                             -ve               -ve               -ve    -ve                  -ve                   -ve
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Discussion
In early studies on the biochemical characterisation of 
colonic mucin, mucins were extracted in the absence of 
denaturing media that could have allowed for endogenous 
proteolysis.16 The first definitive biochemical study on human 
colonic mucus was done by Herrmann et al.10 However 
their study focused on the biochemical characterisation of 
colonic mucins and was not a comparison between normal 
and cancerous tissue. The biochemical aspect of our study 
was undertaken in carefully controlled conditions in which 
extraction and solubilisation of mucins were done in denatur-
ing conditions, to prevent endogenous proteolysis according 
to the method of Carlstedt et al.16 Besides comparing mucins 
in controls and diseased states, we also used immunohisto-
chemical analysis to determine the type of mucin expressed 
in the different states.
In this study 8 samples gave non-extractable pellet mate-
rial; on further analysis only 5 of these pellets were shown 
to have mucin. The median wet weight of the crude scraped 
material was 4 928 mg, which is higher than in previous 
studies. However, despite the higher yield of crude mucus 
in patients in this study (none of whom had received bowel-
prep), the presence of varying amounts of faecal material in 
the resected specimens made the scraping of the mucosal 
surface and the extraction and purification of mucin very dif-
ficult. 
Attempts at using postmortem samples of colonic mucus 
as controls17 have been unsuccessful because cadavers were 
only available 48 - 72 hours after death, for medico-legal 
reasons. Also, tissue samples taken from the colons of these 
cadavers showed a variable degree of autolysis. The advan-
tage of obtaining tissue from resections for trauma was that 
it was fresh. Unfortunately, in this study the tissue was sup-
plied to us in formalin, making it unsuitable for biochemical 
studies and therefore used only for histological and immuno-
histochemical analysis. A resection for sigmoid volvulus (that 
might perhaps be considered ‘normal’) was also used as a 
control sample.
MUC2 is the major colonic mucin, and crude colonic 
mucus is found both as a soluble phase and an insoluble 
glycoprotein complex.10 However in our study only 5 of the 
8 non-extractable pellets had mucin. The reason for this is 
unknown. Reduction of the disulphide bonds has in some 
cases generated oligomers apparently joined by a novel 
reduction-insensitive bond that required treatment with 
trypsin for solubilisation.10 The presence of a ‘tough’ mucus 
gel on the colonic surface is peculiar to the colon and is not 
found in other tracts in the body. The physiological relevance 
of this is not known but it could be that the intestinal surface 
needs both a highly resistant gel and one that allows for sub-
stances to be able to pass through from the intestinal lumen 
into the mucosa.
Our study also confirms the increased expression of acidic 
mucins in cancer of the colon compared with normals.18 
MUC2 was present in all specimens, both normal and dis-
eased. The sigmoid volvulus specimen gave a MUC2 of dif-
ferent charge from the rest of the samples, and we do not 
understand the significance of this. MUC5AC (a gastric 
and respiratory mucin) has reportedly been found in 86% of 
mucinous carcinomas.19 We found expression of MUC5AC in 
2 and MUC5B in 5 diseased specimens. However the num-
bers are too small to be able to interpret these findings.
This work was supported by the South African Medical Research 
Council, and the University of Cape Town Research Fund.
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